R M Chichmanian, P Heudier, B Taillan, J G Fuzibet. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AgedAntineoplastic Agents/adverse effectsAntineoplastic Agents/immunologyCross ReactionsFemaleFilgrastimGranulocyte Colony-Stimulating Factor/immunologyGranulocyte-Macrophage Colony-Stimulating Factor/adverse effectsGranulocyte-Macrophage Colony-Stimulating Factor/immunologyHumansParapsoriasis/chemically inducedRecombinant Proteins/adverse effectsRecombinant Proteins/immunology
Substances: See more » Antineoplastic AgentsRecombinant ProteinsGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactormolgramostimFilgrastim
Year: 1995 PMID: 8571295
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070